---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-24-000063"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:01:28.462618+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ANI Pharmaceuticals shareholders approve Amended 2022 Stock Plan, re-elect directors

## Summary
- At May 21 annual meeting, all eight director nominees elected; Thomas Haughey received 14.8M for, 2.1M against.
- Shareholders ratified EisnerAmper as auditor for FY2024: 18.0M for, 56.7K against.
- Advisory say-on-pay approved: 16.1M for, 762.7K against, 1.2M broker non-votes.
- Amended 2022 Stock Incentive Plan approved: 16.0M for, 871.2K against, 1.2M broker non-votes.
- Plan increases equity pool; forms for director (1-yr cliff) and employee (4-yr graded) restricted stock filed.

## SEC filing metadata
- accession: 0001023024-24-000063
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000063/0001023024-24-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000063/ani-20240521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-24-000063
- JSON: https://secwatch.observer/filing/0001023024-24-000063.json
- Plain text: https://secwatch.observer/filing/0001023024-24-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.